Los Angeles, CA -- (SBWire) -- 04/12/2019 --Sickle cell disease (SCD) is a chronic, inherited blood disorder that impacts hemoglobin, a protein found in red blood cells (RBCs) that carries oxygen throughout the body. The disease is caused by a genetic mutation in the beta-chain of hemoglobin, which results in the formation of abnormal hemoglobin known as sickle hemoglobin (HbS).
The classification of Sickle Cell Anemia Therapeutics includes Blood Transfusion, Pharmacotherapy and Bone Marrow Transplant, and the proportion of Blood Transfusion in 2017 is about 45%, and the proportion of Bone Marrow Transplant in 2017 is about 35%.
Sickle Cell Anemia Therapeutics is widely used for child and adult. The most proportion of Sickle Cell Anemia Therapeutics is for child, and the revenue share in 2017 is about 78%.
America is the largest consumption place, with a consumption market share nearly 54% in 2017. Following America, Europe is the second largest consumption place with the consumption market share of 27%.
Get PDF template of this report: https://www.qyresearch.com/sample-form/form/1076343/global-sickle-cell-anemia-therapeutics-market
In 2018, the global Sickle Cell Anemia Therapeutics market size was 2170 million US$ and it is expected to reach 4500 million US$ by the end of 2025, with a CAGR of 11.0% between 2019 and 2025.
This report studies the Sickle Cell Anemia Therapeutics market size by players, regions, product types and end industries, history data 2014-2018 and forecast data 2019-2025; This report also studies the global market competition landscape, market drivers and trends, opportunities and challenges, risks and entry barriers, sales channels, distributors and Porter's Five Forces Analysis.
This report focuses on the global top players, covered
Emmaus Medical
Addmedica
Gamida Cell
GlycoMimetics
Pfizer
Novartis
Global Blood Therapeutics
Micelle BioPharma
Bluebird Bio
Prolong Pharmaceuticals
Modus Therapeutics
Sangamo Biosciences
Bioverativ
Imara
Ironwood Pharmaceuticals
Market segment by Regions/Countries, this report covers
North America
Europe
China
Rest of Asia Pacific
Central & South America
Middle East & Africa
Market segment by Type, the product can be split into
Blood Transfusion
Pharmacotherapy
Bone Marrow Transplant
Market segment by Application, the market can be split into
Child
Adult
The study objectives of this report are:
To study and forecast the market size of Sickle Cell Anemia Therapeutics in global market.
To analyze the global key players, SWOT analysis, value and global market share for top players.
To define, describe and forecast the market by type, end use and region.
To analyze and compare the market status and forecast among global major regions.
To analyze the global key regions market potential and advantage, opportunity and challenge, restraints and risks.
To identify significant trends and factors driving or inhibiting the market growth.
To analyze the opportunities in the market for stakeholders by identifying the high growth segments.
To strategically analyze each submarket with respect to individual growth trend and their contribution to the market
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.
In this study, the years considered to estimate the market size of Sickle Cell Anemia Therapeutics are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
Get Full Report Now at USD 3,550 @ https://www.qyresearch.com/settlement/pre/ffaad2fb8a9ba9295063d630298949d0,0,1,Global%20Sickle%20Cell%20Anemia%20Therapeutics%20Market%20Report,%20History%20and%20Forecast%202014-2025,%20Breakdown%20Data%20by%20Companies,%20Key%20Regions,%20Types%20and%20Application
About QYResearch
QYResearch always pursuits high product quality with the belief that quality is the soul of business. Through years of effort and supports from the huge number of customer supports, QYResearch consulting group has accumulated creative design methods on many high-quality markets investigation and research team with rich experience. Today, QYResearch has become the brand of quality assurance in the consulting industry.
Sickle Cell Anemia Therapeutics Market Will Expand at 11.0% CAGR Up to 2025: QY Research, Inc.